Acute myocardial infarction complicated by ventricular standstill terminated by thrombolysis and transcutaneous pacing.
Although the overall need for emergency pacing following AMI has reduced with the wide spread use of thrombolysis the availability of transcutaneous pacing offers an emergency non-invasive strategy to optimise circulation following CHB or ventricular standstill. Transcutaneous pacing also facilitates the safe instigation of thrombolytic therapy to achieve reperfusion of the conduction system following AMI.
Castle
Nick
N
Department of EMC&R, Durban University of Technology, South Africa. Nicholas.castle@ntlworld.com
Porter
Crispin
C
Thompson
Beverley
B
D000328:Adult; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D017984:Enoxaparin / Q000008:administration & dosage; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006327:Heart Block / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006339:Heart Rate; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000150:complications* / Q000503:physiopathology; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase